TLDRs:
- Ant A-Fu rebrands AQ and introduces advanced AI health features for users.
- App connects 15 million users to 300,000 doctors and integrated services.
- AI Q&A analyzes images and explains test results without medical diagnosis.
- Data integrations create opportunities for device makers and health platforms.
Ant Group has unveiled significant upgrades to its AI-powered health app AQ, which now carries a new Chinese name, “Ant A-Fu.” Originally launched in June 2025, the app has grown to serve 15 million monthly active users, providing a digital ecosystem for health guidance, AI-assisted consultations, and integrated services.
The upgraded app combines three core features: a health question-and-answer module, an AI health companion for wellness support, and access to a wide range of health services. Users can now log and synchronize health data from popular smart devices, create comprehensive family health profiles, set personalized wellness goals, and receive reminders tailored to their needs.
Enhanced AI Q&A Supports Wellness Guidance
Ant A-Fu’s upgraded Q&A functionality allows the app to analyze uploaded images, simulate clinical consultations, and interpret medical test results. Importantly, the app does not provide medical diagnoses or replace professional care. By positioning itself as a wellness companion rather than a medical device, Ant A-Fu avoids regulatory oversight from China’s National Medical Products Administration (NMPA), which typically requires pre-market approval for devices intended to treat or measure health conditions.
This strategic design ensures that the app can provide educational and triage support while directing users to licensed healthcare providers for formal consultations, effectively balancing usability with compliance.
Access to 300,000 Doctors Expands Care Options
Through its platform, Ant A-Fu connects users to a network of 300,000 doctors, enabling appointment scheduling, medication purchases, and payment using insurance certificates. Over 500 leading physicians collaborate with the app, and Ant’s AI Doctor Agents have successfully handled 27 million inquiries, highlighting the rapid adoption of AI-driven health services.
By bridging AI guidance and real-world medical expertise, Ant A-Fu offers users a hybrid approach to healthcare—leveraging AI for preliminary support and routing them to professionals for deeper care.
Opportunities for Device Makers and Health Platforms
Beyond direct consumer benefits, Ant A-Fu’s upgrades open opportunities for health technology providers. The app’s ability to log and sync health data from smart devices gives wearable makers and chronic disease management brands access to engaged users.
Third-party health app teams and medical device SaaS vendors can integrate Ant A-Fu’s AI consultation layer to enhance retention on their platforms, effectively testing remote monitoring tools and other health features with real-world user data.
The combination of AI-guided support, large-scale user engagement, and regulatory compliance positions Ant A-Fu as a versatile platform for both consumers and health technology providers. As Ant Group continues to expand its AI health ecosystem, the app’s growth underscores the increasing role of digital platforms in bridging everyday wellness with professional healthcare services.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
